SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Scholar Rock Holding Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$40.24+0.34 (+0.85%)
Close on Oct 19, 2026
- Market cap
- $5.26B
- P/E (TTM)
- –
- Dividend yield
- –
Scholar Rock statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Market Cap | $4.90B | $166.30M |
| Enterprise Value | $4.60B | $88.19M |
| PB Ratio | 19.31 | 2.03 |
| P/TBV Ratio | 19.31 | 2.29 |
Income (trailing twelve months)
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Revenue | $0 | $58.34M |
| Operating Income | -$406.36M | -$21.40M |
| Net Income | -$408.59M | -$22.46M |
| EBITDA | -$404.88M | -$16.91M |
| EPS (Diluted) | -$3.32 | -$0.83 |
Returns
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Return on Equity (ROE) | -167.8% | -53.2% |
| Return on Assets (ROA) | -94.6% | -40.9% |
| Return on Capital Employed (ROCE) | -90.0% | -38.1% |
Balance sheet
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $492.09M | $61.43M |
| Total Debt | $196.20M | $118.52M |
| Net Cash (Debt) | $295.89M | $15.35M |
| Net Cash Per Share | $2.43 | $0.66 |
| Equity (Book Value) | $253.78M | $49.09M |
| Book Value Per Share | $2.08 | $1.37 |
| Tangible Book Value | $253.78M | $23.52M |
| Working Capital | $434.94M | $76.81M |
Financial position
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Current Ratio | 7.02 | 3.34 |
| Quick Ratio | 6.81 | 2.44 |
| Debt / Equity | 0.77 | 0.52 |
| Interest Coverage | -38.02 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Operating Cash Flow | -$296.83M | -$12.35M |
| Capital Expenditures | -$185.00K | -$1.08M |
| Free Cash Flow | -$297.01M | -$20.22M |
| FCF Per Share | -$2.44 | -$0.42 |
Efficiency
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.39 |
| Revenue Per Employee | $0 | $404.87K |
| Profits Per Employee | -$1.41M | -$703.34K |
| Employee Count | 289 | 74 |
Dividends and yields
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Earnings Yield | -8.34% | -23.3% |
| FCF Yield | -6.06% | -8.72% |
| Buyback Yield | -5.15% | -0.59% |
| Shareholder Yield | -5.15% | 0.00% |
Shares
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Shares Outstanding | 121,785,000 | 58,127,000 |
| Shares Change (YoY) | 14.1% | 10.9% |
| Shares Change (QoQ) | 2.10% | 0.54% |
| Float | 86,710,100 | 49,136,700 |
| Shares Held by Insiders | 28.8% | 11.6% |
| Shares Held by Institutions | 113.9% | 59.4% |
Scores
| Measure | Scholar Rock | Industry median |
|---|---|---|
| Altman Z-Score | 5.28 | -0.22 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Scholar Rock's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.